Ligand validation:4IRZ

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4IRZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IRZ_NAG_A_3046	52%	73%	0.16	0.918	0.53	0.51	-	-	0	0	100%	0.9333
4IRZ_NAG_A_3105	14%	73%	0.295	0.843	0.52	0.54	-	-	0	0	100%	0.9333
4IRZ_NAG_A_3505	8%	70%	0.31	0.789	0.53	0.63	-	-	0	0	100%	0.6347
4IRZ_NAG_A_3485	6%	72%	0.342	0.779	0.5	0.58	-	-	0	0	100%	0.6813
3V4P_NAG_A_604	84%	69%	0.088	0.95	0.54	0.65	-	-	0	0	100%	0.9333
3V4V_NAG_A_3046	63%	65%	0.153	0.95	0.56	0.77	-	-	1	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.